JP2022108241A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2022108241A5 JP2022108241A5 JP2021055886A JP2021055886A JP2022108241A5 JP 2022108241 A5 JP2022108241 A5 JP 2022108241A5 JP 2021055886 A JP2021055886 A JP 2021055886A JP 2021055886 A JP2021055886 A JP 2021055886A JP 2022108241 A5 JP2022108241 A5 JP 2022108241A5
- Authority
- JP
- Japan
- Prior art keywords
- alkyl
- tautomer
- compound
- occurrence
- pharmaceutically acceptable
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PCT/CN2021/071256 WO2022150962A1 (en) | 2021-01-12 | 2021-01-12 | Protease inhibitors, preparation, and uses thereof |
| CNPCT/CN2021/071256 | 2021-01-12 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022108241A JP2022108241A (ja) | 2022-07-25 |
| JP2022108241A5 true JP2022108241A5 (cg-RX-API-DMAC7.html) | 2022-09-20 |
| JP7611045B2 JP7611045B2 (ja) | 2025-01-09 |
Family
ID=75277880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021055886A Active JP7611045B2 (ja) | 2021-01-12 | 2021-03-29 | プロテアーゼ阻害剤、その調製、および使用 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US11958830B2 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4026830A1 (cg-RX-API-DMAC7.html) |
| JP (1) | JP7611045B2 (cg-RX-API-DMAC7.html) |
| CN (2) | CN113072497B (cg-RX-API-DMAC7.html) |
| WO (1) | WO2022150962A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2019216264B2 (en) | 2018-01-31 | 2023-08-31 | Heparegenix Gmbh | Protein kinase MKK4 inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
| WO2019243315A1 (en) | 2018-06-21 | 2019-12-26 | Heparegenix Gmbh | Tricyclic protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
| SG11202012732UA (en) | 2018-07-16 | 2021-02-25 | Heparegenix Gmbh | Protein kinase inhibitors for promoting liver regeneration or reducing or preventing hepatocyte death |
| JP7629442B2 (ja) | 2019-07-29 | 2025-02-13 | ヘパリジェニックス ゲーエムベーハー | 肝臓再生を促進または肝細胞死を縮減もしくは防止するためのヘテロアリール置換ピラゾロ-ピリジンタンパク質キナーゼ阻害剤 |
| CA3164361A1 (en) | 2020-01-15 | 2021-07-22 | Heparegenix Gmbh | 3-benzoyl-1h-pyrrolo[2,3-b]pyridine derivatives as mkk4 inhibitors for treating liver diseases |
| JP2024178473A (ja) * | 2021-09-03 | 2024-12-25 | 塩野義製薬株式会社 | ウイルス増殖阻害活性を有する二環性含窒素複素環誘導体およびそれらを含有する医薬組成物 |
| WO2023036140A1 (zh) | 2021-09-07 | 2023-03-16 | 上海齐鲁制药研究中心有限公司 | 3CLpro蛋白酶抑制剂 |
| CR20250040A (es) | 2022-08-05 | 2025-03-18 | Gilead Sciences Inc | Inhibidores de la proteasa principal de sars-cov2 |
| US20240158368A1 (en) | 2022-10-14 | 2024-05-16 | Abbvie Inc. | Pyrrolidine Main Protease Inhibitors as Antiviral Agents |
| WO2024124287A1 (en) * | 2022-12-12 | 2024-06-20 | The Walter And Eliza Hall Institute Of Medical Research | Compounds for treating viral infection |
| CN120787158A (zh) * | 2023-03-03 | 2025-10-14 | 齐鲁动物保健品有限公司 | 3CLpro蛋白酶抑制剂在制备治疗猫冠状病毒疾病药物中的用途 |
| JP2026515483A (ja) * | 2023-04-11 | 2026-05-18 | ウエストレイク ファーマシューティカルズ (ハンチョウ) カンパニー、リミテッド | プロテアーゼ阻害剤及びその使用 |
| WO2024243841A1 (zh) | 2023-05-31 | 2024-12-05 | 西湖制药(杭州)有限公司 | 一种病毒蛋白酶抑制剂的结晶及用途 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK175069B1 (da) * | 1986-03-11 | 2004-05-24 | Hoffmann La Roche | Pyrocatecholderivater |
| US6335350B1 (en) | 1998-12-09 | 2002-01-01 | American Home Products Corporation | Acetamide and substituted acetamide-containing thiourea inhibitors of herpes viruses |
| CN1333750A (zh) * | 1998-12-09 | 2002-01-30 | 美国家庭用品有限公司 | 含乙酰胺和取代的乙酰胺的疱疹病毒硫脲抑制剂 |
| EP1137632B1 (en) * | 1998-12-09 | 2004-07-28 | Wyeth | Thiourea inhibitors of herpes viruses |
| TW200306159A (en) | 2002-03-19 | 2003-11-16 | Du Pont | Bicyclic fused pyridinyl amides and advantageous compositions thereof for use as fungicides |
| DE10306250A1 (de) | 2003-02-14 | 2004-09-09 | Aventis Pharma Deutschland Gmbh | Substituierte N-Arylheterozyklen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel |
| US7067529B2 (en) | 2003-05-19 | 2006-06-27 | Hoffmann-La Roche Inc. | Glutamine fructose-y-phosphate amidotransferase (GFAT) inhibitors |
| EP1652525A4 (en) * | 2003-07-15 | 2008-10-01 | Arigen Inc | ANTI-VIRUS CORONA DRUG |
| US7732446B1 (en) * | 2004-03-11 | 2010-06-08 | Takeda Pharmaceutical Company Limited | Dipeptidyl peptidase inhibitors |
| JP2008532933A (ja) * | 2005-02-11 | 2008-08-21 | コーリー ファーマシューティカル グループ,インコーポレイテッド | 置換イミダゾキノリン類および置換イミダゾナフチリジン類 |
| EP2124568A1 (en) * | 2007-01-17 | 2009-12-02 | Merck & Co., Inc. | Decahydroquinoline analogs as cb2 receptor modulators |
| CN101519372B (zh) * | 2009-04-01 | 2011-07-20 | 深圳市盛捷生物技术有限公司 | 用作GSK3抑制剂的苯并[e]异吲哚-1,3-二酮化合物及其制备 |
| WO2011151423A1 (en) | 2010-06-04 | 2011-12-08 | Exonhit S.A. | Substituted isoquinolines and their use as tubulin polymerization inhibitors |
| WO2012090177A2 (en) * | 2010-12-30 | 2012-07-05 | Lupin Limited | Cannabinoid receptor modulators |
| US9206128B2 (en) | 2011-11-18 | 2015-12-08 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| WO2013075084A1 (en) | 2011-11-18 | 2013-05-23 | Constellation Pharmaceuticals | Modulators of methyl modifying enzymes, compositions and uses thereof |
| WO2013078320A1 (en) | 2011-11-21 | 2013-05-30 | Constellation Pharmaceuticals | Modulators of methyl modifying enzymes, compositions and uses thereof |
| CN104334532B (zh) * | 2012-01-30 | 2018-08-14 | 霍夫曼-拉罗奇有限公司 | 异喹啉和二氮杂萘衍生物 |
| US9085583B2 (en) | 2012-02-10 | 2015-07-21 | Constellation—Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| IN2014MN01982A (cg-RX-API-DMAC7.html) * | 2012-04-25 | 2015-07-10 | Raqualia Pharma Inc | |
| WO2014025651A1 (en) | 2012-08-06 | 2014-02-13 | Amgen Inc. | Chroman derivatives as trpm8 inhibitors |
| PL2953941T3 (pl) | 2013-02-11 | 2017-11-30 | Constellation Pharmaceuticals, Inc. | Modulatory enzymów modyfikujących metyl, ich kompozycje i zastosowania |
| US9745305B2 (en) | 2013-03-15 | 2017-08-29 | Constellation Pharmaceuticals, Inc. | Modulators of methyl modifying enzymes, compositions and uses thereof |
| US9969716B2 (en) | 2013-08-15 | 2018-05-15 | Constellation Pharmaceuticals, Inc. | Indole derivatives as modulators of methyl modifying enzymes, compositions and uses thereof |
| KR101715090B1 (ko) * | 2013-08-28 | 2017-03-13 | 한국화학연구원 | 신규한 화합물 또는 이의 약학적으로 허용가능한 염, 및 이를 유효성분으로 함유하는 인플루엔자 바이러스 감염으로 인한 질환의 예방 또는 치료용 약학적 조성물 |
| KR20150027922A (ko) | 2013-09-04 | 2015-03-13 | 주식회사 대웅제약 | 신규한 항진균성 피리디닐하이드라자이드 유도체 |
| WO2016036638A1 (en) * | 2014-09-05 | 2016-03-10 | Merck Sharp & Dohme Corp. | Isoquinoline derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2 |
| WO2017053604A1 (en) | 2015-09-23 | 2017-03-30 | The Regents Of The University Of California | Potent antiviral pyrazolopyridine compounds |
| EP4006012A1 (en) * | 2015-10-15 | 2022-06-01 | Cornell University | Proteasome inhibitors and uses thereof |
| EP3478662B1 (en) * | 2016-06-30 | 2020-09-16 | ViiV Healthcare UK (No.5) Limited | Azadecalin derivatives as inhibitors of human immunodeficiency virus replication |
| CN107674029A (zh) * | 2016-08-02 | 2018-02-09 | 上海迪诺医药科技有限公司 | 多环化合物、其药物组合物及应用 |
| US11247970B2 (en) | 2017-03-22 | 2022-02-15 | Dana-Farber Cancer Institute, Inc. | Selective inhibition of gluconeogenic activity |
| TWI821343B (zh) | 2018-07-27 | 2023-11-11 | 美商共結晶製藥公司 | 流感病毒複製之抑制劑 |
| MA53721A (fr) | 2018-09-28 | 2021-09-15 | Janssen Pharmaceutica Nv | Modulateurs de la monoacylglycérol lipase |
| EP3982954A4 (en) * | 2019-06-14 | 2024-01-03 | The Trustees of Columbia University in the City of New York | NT5C2 INHIBITORS FOR THE TREATMENT OF CHEMOTHERAPY-RESISTANT ACUTE LYMPHOBLASTIC LEUKEMIA |
-
2021
- 2021-01-12 WO PCT/CN2021/071256 patent/WO2022150962A1/en not_active Ceased
- 2021-03-29 EP EP21165625.1A patent/EP4026830A1/en active Pending
- 2021-03-29 JP JP2021055886A patent/JP7611045B2/ja active Active
- 2021-03-29 CN CN202110336891.8A patent/CN113072497B/zh active Active
- 2021-03-29 CN CN202310629540.5A patent/CN116751164B/zh active Active
- 2021-03-29 US US17/215,313 patent/US11958830B2/en active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CA2465117A1 (en) | Lipoxins and their stable analogs in the treatment of asthma and inflammatory airway diseases | |
| JP2022522694A5 (cg-RX-API-DMAC7.html) | ||
| JP2004500426A5 (cg-RX-API-DMAC7.html) | ||
| ME00354B (me) | Novi lekovi za tretiranje hronićnog opstruktivnog oboljenja pluća | |
| BRPI0212894B1 (pt) | Composto ou sal do mesmo farmaceuticamente aceitável e composição farmacêutica | |
| JP2010501584A5 (cg-RX-API-DMAC7.html) | ||
| ATE19878T1 (de) | Benzimidazol-derivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen. | |
| JP2008531479A5 (cg-RX-API-DMAC7.html) | ||
| JP2023518777A5 (cg-RX-API-DMAC7.html) | ||
| KR970025611A (ko) | 치환된 설폰이미다미드, 이의 제조방법,약제 또는 진단제로서의 이의 용도 및 이를 함유하는 약제 | |
| ES2142873T3 (es) | Metodo para tratar infecciones virales. | |
| JP2022526604A5 (cg-RX-API-DMAC7.html) | ||
| JP2022137237A5 (cg-RX-API-DMAC7.html) | ||
| JP2024537784A5 (cg-RX-API-DMAC7.html) | ||
| JP2024504225A5 (cg-RX-API-DMAC7.html) | ||
| JP2024545787A5 (cg-RX-API-DMAC7.html) | ||
| JP2025508656A5 (cg-RX-API-DMAC7.html) | ||
| JP2025507180A (ja) | 肺線維症治療のための薬物の調製におけるヒポキサンチン化合物の使用 | |
| JP2014511897A5 (cg-RX-API-DMAC7.html) | ||
| JPS63502179A (ja) | 新規なアリ−ル誘導体類 | |
| EP1220848B1 (en) | N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv | |
| GB1585963A (en) | Aryl sulphur compounds | |
| JP2022536043A5 (cg-RX-API-DMAC7.html) | ||
| ES513177A0 (es) | "un procedimiento para la preparacion de pirimidin-2-onas sustituidas". | |
| JPH08512279A (ja) | 抗サイトメガロウイルス剤としてのポリアミン誘導体類 |